These results, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two support the idea of concentrating on ACKR3 as a unique solution to modulate the opioid technique, which could open up new therapeutic avenues for opioid-relevant disorders.We independently investigate, evaluat